Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.
about
The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ TransplantationNovel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity.IL-21 Receptor Antagonist Inhibits Differentiation of B Cells toward Plasmablasts upon Alloantigen Stimulation.First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28.Selective CD28 Blockade Results in Superior Inhibition of Donor-Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4-Ig.Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk.Mechanisms of Mixed Chimerism-Based Transplant Tolerance.CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates
P2860
Q28078919-CF5CA744-60EB-4B44-B684-3E50A373F4A9Q36293855-66FE3A4D-A078-40F4-9507-9796EE31540CQ38681685-59BD62C2-0C75-49FC-9B8A-6748A6B21094Q38790777-CE7726EB-889F-48C1-8785-B0A5F9E52CECQ38804454-20FFA1F4-DBE1-4A88-9302-0C741B0E99D4Q38824724-D59D66FF-5DEE-4D6C-B829-85EC94AE9EE2Q39161011-BB6E4AFF-C924-4590-9BC9-09A1E277E199Q41916538-AA746953-986D-438D-A6ED-14E5C6892ED7Q42263289-27BF4508-6CFF-4110-9B2E-5BF86E7937D6Q48223745-B45281A9-6640-426F-9F0B-254B35B09CD3Q48747887-D836F656-8683-4B13-8E26-B7E860AD59A2Q49598430-C37AC921-AC81-400D-A4C6-82DB4CDF7A9EQ50101803-158FE9AA-98F2-4785-8762-A22F7C977AF1Q50102293-E9364CF5-A27A-48F5-82F3-CA4527135206Q53102364-190736FB-E5E9-4A76-8B79-87FBE44A09EEQ56889641-9F40C6C3-F705-4D49-9975-22DD1A61C864
P2860
Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Anti-CD28 Antibody and Belatac ...... of Renal Allograft Rejection.
@en
Anti-CD28 Antibody and Belatac ...... of Renal Allograft Rejection.
@nl
type
label
Anti-CD28 Antibody and Belatac ...... of Renal Allograft Rejection.
@en
Anti-CD28 Antibody and Belatac ...... of Renal Allograft Rejection.
@nl
prefLabel
Anti-CD28 Antibody and Belatac ...... of Renal Allograft Rejection.
@en
Anti-CD28 Antibody and Belatac ...... of Renal Allograft Rejection.
@nl
P2093
P2860
P356
P1476
Anti-CD28 Antibody and Belatac ...... s of Renal Allograft Rejection
@en
P2093
Alexis Chenouard
Caroline Mary
David Minault
Flora Coulon
Gilles Blancho
Jeremy Hervouet
Julien Branchereau
Karine Renaudin
Nicolas Poirier
Sabrina Pengam
P2860
P304
P356
10.1681/ASN.2015070774
P577
2016-05-09T00:00:00Z